+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cell Analysis Market - Global Forecast 2026-2032- Product Image
Cell Analysis Market - Global Forecast 2026-2032- Product Image
New

Cell Analysis Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 190 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011244
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cell analysis market is evolving rapidly as innovation, regulatory changes, and rising clinical needs drive new operational and strategic priorities across the global life sciences sector. Senior leaders must navigate these shifts to optimize investments and remain competitive.

Market Snapshot: Cell Analysis Market Size and Growth Projections

The Cell Analysis Market expanded from USD 26.00 billion in 2025 to USD 27.88 billion in 2026, with a projected CAGR of 10.46% through 2032, reaching USD 52.17 billion. This outlook underscores sustained investment and robust innovation momentum across research laboratories and clinical applications. Increased operational resilience has defined vendor and end-user strategies, while adaptation to emerging technology requirements continues to support healthy market expansion.

Scope & Segmentation

  • Techniques: Cell Sorting, Flow Cytometry, Imaging Cytometry, and Mass Cytometry—each plays a critical role from basic sample purification to advanced immunoprofiling workflows.
  • Applications: Clinical Diagnostics (subdivided into Hematology, Immunology, Oncology), Drug Discovery (with an emphasis on safety testing, target identification), Quality Control, and Research. Each application area reflects unique regulatory environments and performance specifications.
  • End Users: Academic and Research Institutes, Contract Research Organizations, Hospitals and Diagnostic Centers, plus Pharmaceutical and Biotechnology Companies. These end users require tailored procurement approaches and varying levels of instrument servicing and support.
  • Regional Coverage: Americas, Europe Middle East & Africa, and Asia-Pacific. Distinct regional funding models, regulatory demands, and adoption timelines all influence market access and platform implementation.
  • Technological Drivers: Machine learning integration, automation of sample-to-answer processes, and interoperability standards now underpin product development and customer value delivery across all market segments.

Key Takeaways: Strategic Insights for Leaders

  • Advanced analytics and flexible modular instruments are essential for adapting to the progression of research and clinical workflows.
  • Effective collaboration among engineering, bioinformatics, and clinical operations accelerates the translation of analysis into actionable outcomes, supporting strategic decision-making.
  • New business models such as device-as-a-service and recurring consumables are enabling vendors to build more sustainable customer relationships and expand value-added services.
  • Decentralization extends cell analysis capabilities into broader clinical and translational environments, helped by validated software platforms and strengthened data-management protocols.
  • Onboarding and post-sale service—including remote diagnostics and professional training—are critical to shortening time-to-insight and maximizing user adoption, ultimately enhancing operational efficiency.
  • Developing robust informatics infrastructure and supporting ongoing professional expertise remain priorities for organizations aiming to capitalize on next-generation system capabilities.

Tariff Impact: Operational and Supply Chain Adaptation

Recent tariff changes and global trade measures have prompted organizations to adjust procurement strategies and supply chains. Companies are mitigating sourcing risks by diversifying suppliers and increasing safety stocks of critical consumables. Alternative vendor qualification and, where feasible, regionalized manufacturing have become central to reducing exposure and improving lead times. As organizations look beyond product features, supply chain resilience now carries equal weight with system performance during partnership evaluations—particularly for clinical laboratories and contract research organizations seeking uninterrupted workflow.

Cell Analysis Market Methodology & Data Sources

Findings for this report are grounded in a systematic approach. This includes a thorough literature review, structured interviews with instrument engineers and laboratory leadership, and validation against published peer-reviewed articles and technical documentation. Primary and secondary sources are cross-verified to ensure robust, unbiased conclusions.

Why This Report Matters

  • Senior executives gain a detailed, actionable perspective on evolving cell analysis technologies, new workflow implementations, and emerging industry business models.
  • The report clarifies region-specific adoption patterns and regulatory requirements, enabling data-driven strategy for international market entry or expansion.
  • Decision-makers can benchmark their operational resilience, platform integration, and engagement practices against best-in-class approaches shaping the sector.

Conclusion

The convergence of evolving instrumentation, shifting clinical requirements, and robust supply chain management is redefining the cell analysis market. Leaders who prioritize integration, modularity, and validated workflow design are poised to create lasting value in an increasingly dynamic landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Cell Analysis Market, by Technique
8.1. Cell Sorting
8.2. Flow Cytometry
8.3. Imaging Cytometry
8.4. Mass Cytometry
9. Cell Analysis Market, by Application
9.1. Clinical Diagnostics
9.1.1. Hematology
9.1.2. Immunology
9.1.3. Oncology
9.2. Drug Discovery
9.2.1. Safety Testing
9.2.2. Target Identification
9.3. Quality Control
9.4. Research
10. Cell Analysis Market, by End User
10.1. Academic And Research Institutes
10.2. Contract Research Organizations
10.3. Hospitals And Diagnostic Centers
10.4. Pharmaceutical And Biotechnology Companies
11. Cell Analysis Market, by Region
11.1. Americas
11.1.1. North America
11.1.2. Latin America
11.2. Europe, Middle East & Africa
11.2.1. Europe
11.2.2. Middle East
11.2.3. Africa
11.3. Asia-Pacific
12. Cell Analysis Market, by Group
12.1. ASEAN
12.2. GCC
12.3. European Union
12.4. BRICS
12.5. G7
12.6. NATO
13. Cell Analysis Market, by Country
13.1. United States
13.2. Canada
13.3. Mexico
13.4. Brazil
13.5. United Kingdom
13.6. Germany
13.7. France
13.8. Russia
13.9. Italy
13.10. Spain
13.11. China
13.12. India
13.13. Japan
13.14. Australia
13.15. South Korea
14. United States Cell Analysis Market
15. China Cell Analysis Market
16. Competitive Landscape
16.1. Market Concentration Analysis, 2025
16.1.1. Concentration Ratio (CR)
16.1.2. Herfindahl Hirschman Index (HHI)
16.2. Recent Developments & Impact Analysis, 2025
16.3. Product Portfolio Analysis, 2025
16.4. Benchmarking Analysis, 2025
16.5. 10x Genomics
16.6. Agilent Technologies, Inc.
16.7. Becton, Dickinson and Company
16.8. Bio-Rad Laboratories, Inc.
16.9. Corning Incorporated
16.10. Cytek Biosciences
16.11. Danaher Corporation
16.12. F. Hoffmann-La Roche AG
16.13. GE HealthCare Technologies Inc.
16.14. Illumina
16.15. Lonza Group AG
16.16. Merck KGaA
16.17. Miltenyi Biotec
16.18. Olympus Corporation
16.19. PerkinElmer, Inc.
16.20. Promega Corporation
16.21. QIAGEN N.V.
16.22. Sartorius AG
16.23. Sysmex Corporation
16.24. Takara Bio Inc.
16.25. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL CELL ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CELL ANALYSIS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CELL ANALYSIS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CELL ANALYSIS MARKET SIZE, BY TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CELL ANALYSIS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CELL ANALYSIS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CELL ANALYSIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CELL ANALYSIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. UNITED STATES CELL ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 11. CHINA CELL ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CELL ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CELL ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL SORTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL SORTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL SORTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CELL ANALYSIS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CELL ANALYSIS MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CELL ANALYSIS MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CELL ANALYSIS MARKET SIZE, BY IMAGING CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CELL ANALYSIS MARKET SIZE, BY IMAGING CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CELL ANALYSIS MARKET SIZE, BY IMAGING CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CELL ANALYSIS MARKET SIZE, BY MASS CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CELL ANALYSIS MARKET SIZE, BY MASS CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CELL ANALYSIS MARKET SIZE, BY MASS CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CELL ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CELL ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CELL ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CELL ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CELL ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CELL ANALYSIS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CELL ANALYSIS MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CELL ANALYSIS MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CELL ANALYSIS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CELL ANALYSIS MARKET SIZE, BY IMMUNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CELL ANALYSIS MARKET SIZE, BY IMMUNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CELL ANALYSIS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CELL ANALYSIS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CELL ANALYSIS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CELL ANALYSIS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CELL ANALYSIS MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CELL ANALYSIS MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CELL ANALYSIS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CELL ANALYSIS MARKET SIZE, BY SAFETY TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CELL ANALYSIS MARKET SIZE, BY SAFETY TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CELL ANALYSIS MARKET SIZE, BY SAFETY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CELL ANALYSIS MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CELL ANALYSIS MARKET SIZE, BY TARGET IDENTIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CELL ANALYSIS MARKET SIZE, BY TARGET IDENTIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CELL ANALYSIS MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CELL ANALYSIS MARKET SIZE, BY QUALITY CONTROL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CELL ANALYSIS MARKET SIZE, BY QUALITY CONTROL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CELL ANALYSIS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CELL ANALYSIS MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CELL ANALYSIS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CELL ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CELL ANALYSIS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CELL ANALYSIS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CELL ANALYSIS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CELL ANALYSIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CELL ANALYSIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CELL ANALYSIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CELL ANALYSIS MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CELL ANALYSIS MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CELL ANALYSIS MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CELL ANALYSIS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CELL ANALYSIS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CELL ANALYSIS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CELL ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. AMERICAS CELL ANALYSIS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 60. AMERICAS CELL ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 61. AMERICAS CELL ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 62. AMERICAS CELL ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 63. AMERICAS CELL ANALYSIS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 64. AMERICAS CELL ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 65. NORTH AMERICA CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. NORTH AMERICA CELL ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 67. NORTH AMERICA CELL ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 68. NORTH AMERICA CELL ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 69. NORTH AMERICA CELL ANALYSIS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 70. NORTH AMERICA CELL ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 71. LATIN AMERICA CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. LATIN AMERICA CELL ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 73. LATIN AMERICA CELL ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 74. LATIN AMERICA CELL ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 75. LATIN AMERICA CELL ANALYSIS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 76. LATIN AMERICA CELL ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA CELL ANALYSIS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA CELL ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA CELL ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA CELL ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA CELL ANALYSIS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA CELL ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 83. EUROPE CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. EUROPE CELL ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 85. EUROPE CELL ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 86. EUROPE CELL ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 87. EUROPE CELL ANALYSIS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 88. EUROPE CELL ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 89. MIDDLE EAST CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. MIDDLE EAST CELL ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 91. MIDDLE EAST CELL ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 92. MIDDLE EAST CELL ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 93. MIDDLE EAST CELL ANALYSIS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 94. MIDDLE EAST CELL ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 95. AFRICA CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. AFRICA CELL ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 97. AFRICA CELL ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 98. AFRICA CELL ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 99. AFRICA CELL ANALYSIS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 100. AFRICA CELL ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 101. ASIA-PACIFIC CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. ASIA-PACIFIC CELL ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC CELL ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC CELL ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC CELL ANALYSIS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC CELL ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL CELL ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. ASEAN CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. ASEAN CELL ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 110. ASEAN CELL ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 111. ASEAN CELL ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 112. ASEAN CELL ANALYSIS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 113. ASEAN CELL ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 114. GCC CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GCC CELL ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 116. GCC CELL ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 117. GCC CELL ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 118. GCC CELL ANALYSIS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 119. GCC CELL ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. EUROPEAN UNION CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. EUROPEAN UNION CELL ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 122. EUROPEAN UNION CELL ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 123. EUROPEAN UNION CELL ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 124. EUROPEAN UNION CELL ANALYSIS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 125. EUROPEAN UNION CELL ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 126. BRICS CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. BRICS CELL ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 128. BRICS CELL ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 129. BRICS CELL ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 130. BRICS CELL ANALYSIS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 131. BRICS CELL ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 132. G7 CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. G7 CELL ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 134. G7 CELL ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 135. G7 CELL ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 136. G7 CELL ANALYSIS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 137. G7 CELL ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 138. NATO CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. NATO CELL ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 140. NATO CELL ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 141. NATO CELL ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 142. NATO CELL ANALYSIS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 143. NATO CELL ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. UNITED STATES CELL ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 146. UNITED STATES CELL ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 147. UNITED STATES CELL ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 148. UNITED STATES CELL ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 149. UNITED STATES CELL ANALYSIS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 150. UNITED STATES CELL ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 151. CHINA CELL ANALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 152. CHINA CELL ANALYSIS MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 153. CHINA CELL ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 154. CHINA CELL ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 155. CHINA CELL ANALYSIS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 156. CHINA CELL ANALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Cell Analysis market report include:
  • 10x Genomics
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Corning Incorporated
  • Cytek Biosciences
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • GE HealthCare Technologies Inc.
  • Illumina
  • Lonza Group AG
  • Merck KGaA
  • Miltenyi Biotec
  • Olympus Corporation
  • PerkinElmer, Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Sartorius AG
  • Sysmex Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages190
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 27.88 Billion
Forecasted Market Value ( USD ) by 2032 $ 52.17 Billion
Compound Annual Growth Rate10.4%
Regions CoveredGlobal
No. of Companies Mentioned22

Related Topics

Related Reports

Single Cell Analysis Market - Global Forecast 2026-2032 - Product Image

Single Cell Analysis Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Microfluidic Single-Cell Analysis & Screening System Market - Global Forecast 2025-2030 - Product Image

Microfluidic Single-Cell Analysis & Screening System Market - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Single Cell Analysis Market by Product (Consumables (Beads, Kits, Reagents), Instruments), Cell Type (Human, Animal), Technique (Flow Cytometry, NGS, PCR, Microscopy), Application (Research (Cancer, Neurology), Medical (NIPT, IVF)) - Global Forecast to 2030 - Product Image

Single Cell Analysis Market by Product (Consumables (Beads, Kits, Reagents), Instruments), Cell Type (Human, Animal), Technique (Flow Cytometry, NGS, PCR, Microscopy), Application (Research (Cancer, Neurology), Medical (NIPT, IVF)) - Global Forecast to 2030

  • Report
  • 518 Pages
  • Global
From
Cancer Cell Analysis Market Report 2025 - Product Image

Cancer Cell Analysis Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Cell Analysis - Global Strategic Business Report - Product Image

Cell Analysis - Global Strategic Business Report

  • Report
  • 273 Pages
  • Global
From

About the Market

The Cell Analysis market within the context of Genomics is a rapidly growing field that focuses on the study of cells and their components. It involves the use of various technologies such as flow cytometry, imaging, and mass spectrometry to analyze the structure and function of cells. This market is driven by the increasing demand for personalized medicine, the development of new technologies, and the need for better understanding of diseases. Cell Analysis is used to study the behavior of cells in different environments, to identify biomarkers, and to develop new treatments. It is also used to study the effects of drugs on cells, to identify new targets for drug development, and to develop new diagnostic tests. Some of the major companies in the Cell Analysis market include Thermo Fisher Scientific, Illumina, Becton Dickinson, Agilent Technologies, Merck KGaA, and PerkinElmer. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.